Cargando…
Development and validation of a simple and rapid way to generate low volume of plasma to be used in point-of-care HIV virus load technologies
A new point-of-care HIV viral load, mPIMA HIV-1/2 VL, Abbott, USA, has been recently developed. This point-of-care viral load requires no skilled person to run and uses a small plasma volume (50 μL). However, obtaining 50 μL of plasma can be a challenge in limited resource settings. We validated a s...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392034/ https://www.ncbi.nlm.nih.gov/pubmed/31760036 http://dx.doi.org/10.1016/j.bjid.2019.10.010 |